BI 3000202_low dose clinical trials

A Study to Test How Well BI 3000202 is Tolerated by People With Type 1 Interferonopathies

This study is for adults with specific rare conditions called Type 1 Interferonopathies, such as Aicardi-Goutières syndrome. It will test a new medicine, BI 3000202, to see how well people tolerate different doses over several months, alongside their usual care.